Halozyme (HALO) EV/EBITDA US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
EV/EBITDA ? 22.4 3.62 2.57 10.6 17.6   10.3  
Changes by years, y/y, % -42% -84% -29% +313% +65%     -14.4%

Halozyme. EV/EBITDA

Halozyme. EV/EBITDA, changes, %

Halozyme (HALO) EV/EBITDA US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
EV/EBITDA ? 12.4 9.27 11.2 17.5 15.2   10.3
Changes by years, y/y, % +488% +385% -21% +63% +22%    
Changes by quarters, q/q, % +16% -26% +21% +56% -13%    

Halozyme. EV/EBITDA

Halozyme. EV/EBITDA, changes, y/y, %

Halozyme. EV/EBITDA, changes, q/q, %